Leede Financial launched coverage of Nanalysis Scientific (TSXV: NSCI) (OTCQX: NSCIF) with a “speculative buy” rating and C$0.90 target price. The stock closed at $0.365 on November 22. Nanalysis operates two distinct...
Echelon Capital Markets initiated coverage to Nanalysis Scientific (TSXV:NSCI) with a “buy” rating and price target of $2.85 (Canadian). The stock closed at $1.10 on Sept. 21. “Nanalysis is a provisioner of compact...